These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 16099718

  • 1. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 4. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
    U.S. Xyrem Multicenter Study Group.
    Sleep Med; 2004 Mar 01; 5(2):119-23. PubMed ID: 15033130
    [Abstract] [Full Text] [Related]

  • 5. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 01; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 6. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 01; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 7. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ.
    Rev Neurol; 2009 Sep 01; 48(1):27-31. PubMed ID: 19145563
    [Abstract] [Full Text] [Related]

  • 8. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549
    [Abstract] [Full Text] [Related]

  • 9. Sodium oxybate for cataplexy.
    Lemon MD, Strain JD, Farver DK.
    Ann Pharmacother; 2006 Mar 15; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [Abstract] [Full Text] [Related]

  • 10. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb 01; 26(1):31-5. PubMed ID: 12627729
    [Abstract] [Full Text] [Related]

  • 11. Weight loss in narcolepsy patients treated with sodium oxybate.
    Husain AM, Ristanovic RK, Bogan RK.
    Sleep Med; 2009 Jun 01; 10(6):661-3. PubMed ID: 19014899
    [Abstract] [Full Text] [Related]

  • 12. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP, Kotagal S.
    Sleep Med; 2012 Jun 01; 13(6):606-10. PubMed ID: 22445591
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group.
    Arthritis Rheum; 2009 Jan 01; 60(1):299-309. PubMed ID: 19116896
    [Abstract] [Full Text] [Related]

  • 14. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
    Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ.
    CNS Drugs; 2022 Jun 01; 36(6):633-647. PubMed ID: 35635687
    [Abstract] [Full Text] [Related]

  • 15. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    Lancet Child Adolesc Health; 2018 Jul 01; 2(7):483-494. PubMed ID: 30169321
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
    Borgen LA, Okerholm RA, Lai A, Scharf MB.
    J Clin Pharmacol; 2004 Mar 01; 44(3):253-7. PubMed ID: 14973300
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 18. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS, Guilleminault C.
    Pediatr Neurol; 2009 Jul 01; 41(1):9-16. PubMed ID: 19520267
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
    Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ.
    CNS Drugs; 2023 Apr 01; 37(4):323-335. PubMed ID: 36947322
    [Abstract] [Full Text] [Related]

  • 20. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R, Tartarotti S, Khatami R, Baumann CR, Valko P, Kallweit U, Werth E, Bassetti CL.
    Eur Neurol; 2011 Apr 01; 65(3):175-82. PubMed ID: 21389728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.